{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:58:39Z","timestamp":1763398719077},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.mehy.2016.05.031","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T16:11:11Z","timestamp":1464451871000},"page":"126-131","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anthropogenic and temporal components in a complex trigger of type 1 diabetes suggest the active participation of antipyretics"],"prefix":"10.1016","volume":"93","author":[{"given":"Darijus","family":"Veteikis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Special Issue","key":"10.1016\/j.mehy.2016.05.031_b0005","year":"2015","journal-title":"BioMed Res Int"},{"issue":"7","key":"10.1016\/j.mehy.2016.05.031_b0010","doi-asserted-by":"crossref","first-page":"a007690","DOI":"10.1101\/cshperspect.a007690","article-title":"Environmental triggers of type 1 diabetes","volume":"2","author":"Knip","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.mehy.2016.05.031_b0015","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.humimm.2014.09.009","article-title":"The Raikas \u2013 a unique combination of high prevalence of type 1 diabetes susceptibility genes and near zero incidence of the disease","volume":"75","author":"Bhat","year":"2014","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12016-011-8291-x","article-title":"Leaky gut and autoimmune diseases","volume":"42","author":"Fasano","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.mehy.2016.05.031_b0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/(SICI)1096-9136(199809)15:9<730::AID-DIA646>3.0.CO;2-C","article-title":"Cow\u2019s milk consumption, disease-associated autoantibodies and type 1 diabetes mellitus: a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group","volume":"15","author":"Virtanen","year":"1998","journal-title":"Diabetic Med"},{"key":"10.1016\/j.mehy.2016.05.031_b0030","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1055\/s-2007-1023884","article-title":"The significance of A1 and A2 antibodies against beta-casein in type-1 diabetes mellitus","volume":"124","author":"Padberg","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diacare.17.1.13","article-title":"Cow\u2019s milk exposure and type I diabetes mellitus: a critical overview of the clinical literature","volume":"17","author":"Gerstein","year":"1994","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1096-9136(199601)13:1<23::AID-DIA4>3.0.CO;2-D","article-title":"The relationship between cow\u2019s milk exposure and type 1 diabetes","volume":"13","author":"Gerstein","year":"1996","journal-title":"Diabetic Med"},{"issue":"10","key":"10.1016\/j.mehy.2016.05.031_b0045","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/diabetes.49.10.1657","article-title":"Effect of cow\u2019s milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group","volume":"49","author":"Paronen","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2016.05.031_b0050","first-page":"149","article-title":"Viruses and type 1 diabetes: a new look at an old story","volume":"14","author":"Craig","year":"2013","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0055","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 is associated with induction of b-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/db13-0620","article-title":"Virus antibody survey in different European populations indicates risk association between Coxsackievirus B1 and type 1 diabetes","volume":"63","author":"Oikarinen","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.031_b0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/08830185.2014.889130","article-title":"Role of viruses and other microbes in the pathogenesis of type 1 diabetes","volume":"33","author":"Kondrashova","year":"2014","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4161\/hv.34309","article-title":"Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease: an open issue","volume":"11","author":"Zanoni","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.mehy.2016.05.031_b0075","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4239\/wjd.v6.i6.828","article-title":"Enterovirus and type 1 diabetes: what is the matter?","volume":"6","author":"Bergamin","year":"2015","journal-title":"World J Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0080","first-page":"86","article-title":"Autoimmune diseases and vaccinations","volume":"14","author":"Vil","year":"2004","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.mehy.2016.05.031_b0085","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1054\/mehy.2001.1352","article-title":"Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action","volume":"57","author":"Classen","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2016.05.031_b0090","article-title":"Childhood bereavement and type 1 diabetes: a danish national register study","author":"Virk","year":"2015","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"3","key":"10.1016\/j.mehy.2016.05.031_b0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1464-5491.2007.02351.x","article-title":"No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database","volume":"25","author":"Cardwell","year":"2008","journal-title":"Diabetic Med"},{"issue":"9","key":"10.1016\/j.mehy.2016.05.031_b0100","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00125-013-2929-6","article-title":"The prenatal environment and type 1 diabetes","volume":"56","author":"Stene","year":"2013","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.mehy.2016.05.031_b0105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jmv.24127","article-title":"Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children","volume":"87","author":"Nilsson","year":"2015","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2015.01.001","article-title":"The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2016.05.031_b0115","doi-asserted-by":"crossref","first-page":"208947","DOI":"10.1155\/2015\/208947","article-title":"Can exposure to environmental chemicals increase the risk of diabetes type 1 development?","volume":"2015","author":"Bodin","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/07853890410018952","article-title":"A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland","volume":"37","author":"Kondrashova","year":"2005","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.mehy.2016.05.031_b0125","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/db13-1775","article-title":"Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility","volume":"63","author":"Kallionp\u00e4\u00e4","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.mehy.2016.05.031_b0130","first-page":"364","article-title":"Did acetaminophen provoke the autism epidemic?","volume":"14","author":"Good","year":"2009","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.mehy.2016.05.031_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14200\/jrm.2013.2.0101","article-title":"Evidence that increase acetaminophen use in genetically vulnerably children appears to be a major cause of the epidemics of autism, attention deficit with hyperactivity, and asthma","volume":"2","author":"Shaw","year":"2013","journal-title":"J Restor Med"},{"key":"10.1016\/j.mehy.2016.05.031_b0140","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(08)61445-2","article-title":"Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6\u20137 years: analysis from Phase Three of the ISAAC programme","volume":"372","author":"Beasley","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mehy.2016.05.031_b0145","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1542\/peds.2011-1106","article-title":"The association of acetaminophen and asthma prevalence and severity","volume":"128","author":"McBride","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.mehy.2016.05.031_b0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1871528112666131219163405","article-title":"The Alzheimer pandemic: is paracetamol to blame?","volume":"13","author":"Jones","year":"2014","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.mehy.2016.05.031_b0155","first-page":"381","article-title":"Acetaminophen-induced alterations in blood glucose and blood insulin levels in mice","volume":"43","author":"Hinson","year":"1984","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"359","key":"10.1016\/j.mehy.2016.05.031_b0160","first-page":"259","article-title":"Apparent hyperglycaemia in paracetamol overdose","volume":"42","author":"Copland","year":"1992","journal-title":"Br J Gen Pract"},{"issue":"841","key":"10.1016\/j.mehy.2016.05.031_b0165","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/pgmj.71.841.702","article-title":"Hyperglycaemia induced by paracetamol","volume":"71","author":"Lawrence","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.mehy.2016.05.031_b0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/jhep.2001.25514","article-title":"Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen","volume":"34","author":"Clark","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0175","first-page":"72","article-title":"Acetaminophen: beyond pain and Fever-relieving","volume":"9","author":"Blough","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.mehy.2016.05.031_b0180","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ijo.2009.291","article-title":"Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole","volume":"34","author":"Shertzer","year":"2010","journal-title":"Int J Obes (London)"},{"issue":"1\u20134","key":"10.1016\/j.mehy.2016.05.031_b0185","first-page":"81","article-title":"Apie vaik\u0173 1 tipo cukrinio diabeto etiologij\u0105. (On the etiology of children T1DM)","volume":"18","author":"Skrodenien\u0117","year":"2010","journal-title":"Lietuvos endokrinologija (Lithuanian Endocrinology)"},{"key":"10.1016\/j.mehy.2016.05.031_b0190","unstructured":"FAO statistics division. Food balance sheets: Milk consumption \u2013 excluding butter. Available from <http:\/\/faostat3.fao.org\/download\/FB\/FBS\/E>; (2014) [accessed 31.10.14]."},{"key":"10.1016\/j.mehy.2016.05.031_b0195","unstructured":"Finnish Medicines Agency Fimea and Social Insurance Institution (2010), Finnish Statistics on Medicines 2009, Helsinki."},{"key":"10.1016\/j.mehy.2016.05.031_b0200","unstructured":"Ravimiamet, State Agency on Medicines (2008), Estonian statistics on medicine 2006\u20132007, Tartu."},{"key":"10.1016\/j.mehy.2016.05.031_b0205","unstructured":"Latvian State Agency on Medicines (2014), Statistics on medicines consumption 2013, Riga."},{"key":"10.1016\/j.mehy.2016.05.031_b0210","author":"Lasinskas"},{"issue":"7","key":"10.1016\/j.mehy.2016.05.031_b0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-5491.2009.02743.x","article-title":"Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide","volume":"26","author":"Moltchanova","year":"2009","journal-title":"Diabetic Med"},{"issue":"1778","key":"10.1016\/j.mehy.2016.05.031_b0220","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2013.2570","article-title":"Population-level effects of suppressing fever","volume":"281","author":"Earn","year":"2014","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.mehy.2016.05.031_b0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.18773\/austprescr.1995.039","article-title":"Paracetamol: use in children","volume":"18","author":"Shann","year":"1995","journal-title":"Australian Prescriber"},{"issue":"2","key":"10.1016\/j.mehy.2016.05.031_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1248\/bpb.25.201","article-title":"Inhibition of the antibody production by acetaminophen independent of liver injury in mice","volume":"25","author":"Yamaura","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.mehy.2016.05.031_b0235","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-1023","article-title":"Viral trigger for type 1 diabetes: pros and cons","volume":"57","author":"Filippi","year":"2008","journal-title":"Diabetes"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716301840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T12:21:41Z","timestamp":1536668501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716301840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":47,"alternative-id":["S0306987716301840"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthropogenic and temporal components in a complex trigger of type 1 diabetes suggest the active participation of antipyretics","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}